Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Technology (NGS, Application, Others), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others), By Type (DNA-Based Targeted Sequencing, RNA-Based Targeted Sequencing), By End Use (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, Other Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Targeted DNA RNA Sequencing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. NGS
      1. Method
      2. Exome Sequencing
      3. Enrichment Sequencing
      4. Amplicon Sequencing
      5. Others
    2. Application
      1. Cancer Gene Sequencing
      2. Inherited Disease Screening
      3. Drug Development
      4. Forensic Genomics
      5. 16S ribosomal RNA (rRNA) sequencing
    3. Others
  2. Targeted DNA RNA Sequencing Market, By Workflow 2022-2034 (USD MILLION/ Units)
    1. Pre-sequencing
    2. Sequencing
    3. Data Analysis
  3. Targeted DNA RNA Sequencing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Human Biomedical Research
    2. Plant & Animal Sciences
    3. Drug Discovery
    4. Others
  4. Targeted DNA RNA Sequencing Market, By Type 2022-2034 (USD MILLION/ Units)
    1. DNA-Based Targeted Sequencing
    2. RNA-Based Targeted Sequencing
  5. Targeted DNA RNA Sequencing Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Academic Research
    2. Hospitals & Clinics
    3. Pharma & Biotech Entities
    4. Other Users
  6. Regional Targeted DNA RNA Sequencing Market
    1. North America
      1. North America Targeted DNA RNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
      2. North America Targeted DNA RNA Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Pre-sequencing
        2. Sequencing
        3. Data Analysis
      3. North America Targeted DNA RNA Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Human Biomedical Research
        2. Plant & Animal Sciences
        3. Drug Discovery
        4. Others
      4. North America Targeted DNA RNA Sequencing Market By Type 2022-2034 (USD MILLION/ Units)
        1. DNA-Based Targeted Sequencing
        2. RNA-Based Targeted Sequencing
      5. North America Targeted DNA RNA Sequencing Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Hospitals & Clinics
        3. Pharma & Biotech Entities
        4. Other Users
      6. U.S.
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      7. Canada
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
    2. Europe
      1. Europe Targeted DNA RNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
      2. Europe Targeted DNA RNA Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Pre-sequencing
        2. Sequencing
        3. Data Analysis
      3. Europe Targeted DNA RNA Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Human Biomedical Research
        2. Plant & Animal Sciences
        3. Drug Discovery
        4. Others
      4. Europe Targeted DNA RNA Sequencing Market By Type 2022-2034 (USD MILLION/ Units)
        1. DNA-Based Targeted Sequencing
        2. RNA-Based Targeted Sequencing
      5. Europe Targeted DNA RNA Sequencing Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Hospitals & Clinics
        3. Pharma & Biotech Entities
        4. Other Users
      6. U.K.
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      7. Germany
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      8. France
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      9. Spain
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      10. Italy
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      11. Russia
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      12. Nordic
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      13. Benelux
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      14. Rest of Europe
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
    3. APAC
      1. APAC Targeted DNA RNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
      2. APAC Targeted DNA RNA Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Pre-sequencing
        2. Sequencing
        3. Data Analysis
      3. APAC Targeted DNA RNA Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Human Biomedical Research
        2. Plant & Animal Sciences
        3. Drug Discovery
        4. Others
      4. APAC Targeted DNA RNA Sequencing Market By Type 2022-2034 (USD MILLION/ Units)
        1. DNA-Based Targeted Sequencing
        2. RNA-Based Targeted Sequencing
      5. APAC Targeted DNA RNA Sequencing Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Hospitals & Clinics
        3. Pharma & Biotech Entities
        4. Other Users
      6. China
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      7. Korea
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      8. Japan
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      9. India
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      10. Australia
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      11. Taiwan
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      12. South East Asia
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      13. Rest of Asia-Pacific
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
    4. Middle East and Africa
      1. Middle East and Africa Targeted DNA RNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
      2. Middle East and Africa Targeted DNA RNA Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Pre-sequencing
        2. Sequencing
        3. Data Analysis
      3. Middle East and Africa Targeted DNA RNA Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Human Biomedical Research
        2. Plant & Animal Sciences
        3. Drug Discovery
        4. Others
      4. Middle East and Africa Targeted DNA RNA Sequencing Market By Type 2022-2034 (USD MILLION/ Units)
        1. DNA-Based Targeted Sequencing
        2. RNA-Based Targeted Sequencing
      5. Middle East and Africa Targeted DNA RNA Sequencing Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Hospitals & Clinics
        3. Pharma & Biotech Entities
        4. Other Users
      6. UAE
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      7. Turkey
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      8. Saudi Arabia
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      9. South Africa
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      10. Egypt
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      11. Nigeria
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      12. Rest of MEA
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
    5. LATAM
      1. LATAM Targeted DNA RNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
      2. LATAM Targeted DNA RNA Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. Pre-sequencing
        2. Sequencing
        3. Data Analysis
      3. LATAM Targeted DNA RNA Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Human Biomedical Research
        2. Plant & Animal Sciences
        3. Drug Discovery
        4. Others
      4. LATAM Targeted DNA RNA Sequencing Market By Type 2022-2034 (USD MILLION/ Units)
        1. DNA-Based Targeted Sequencing
        2. RNA-Based Targeted Sequencing
      5. LATAM Targeted DNA RNA Sequencing Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Hospitals & Clinics
        3. Pharma & Biotech Entities
        4. Other Users
      6. Brazil
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      7. Mexico
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      8. Argentina
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      9. Chile
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      10. Colombia
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users
      11. Rest of LATAM
        1. NGS
          1. Method
          2. Exome Sequencing
          3. Enrichment Sequencing
          4. Amplicon Sequencing
          5. Others
        2. Application
          1. Cancer Gene Sequencing
          2. Inherited Disease Screening
          3. Drug Development
          4. Forensic Genomics
          5. 16S ribosomal RNA (rRNA) sequencing
        3. Others
        4. Pre-sequencing
        5. Sequencing
        6. Data Analysis
        7. Human Biomedical Research
        8. Plant & Animal Sciences
        9. Drug Discovery
        10. Others
        11. DNA-Based Targeted Sequencing
        12. RNA-Based Targeted Sequencing
        13. Academic Research
        14. Hospitals & Clinics
        15. Pharma & Biotech Entities
        16. Other Users

We are featured on: